Skip to main navigation Skip to search Skip to main content

The HMG-CoA reductase inhibitor simvastatin exhibits antitumorigenic and antimetastatic effects in ovarian cancer

  • J.E. Stine
  • , X. Han
  • , M. Schointuch
  • , C. Zhou
  • , T. Gilliam
  • , P.A. Gehrig
  • , V.L. Bae-Jump
  • University of North Carolina at Chapel Hill

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalGynecologic Oncology
Volume133
DOIs
StatePublished - Jun 1 2014
Externally publishedYes

Disciplines

  • Pharmacology
  • Medicine and Health Sciences

Cite this